Poll: Americans Back Research--But Selectively

The public strongly supports scientific research, according to a recent poll from Louis Harris and Associates Inc., but shows marked favoritism when asked to choose among fields. Of eight areas, medical research was rated as "most valuable" by almost half of those polled--49 percent--while environmental and energy investigation were so ranked by 29 percent and 10 percent, respectively. At the bottom end of the sampling, only 1 percent to 3 percent of the people questioned gave top votes to el

Written byFranklin Hoke
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Of eight areas, medical research was rated as "most valuable" by almost half of those polled--49 percent--while environmental and energy investigation were so ranked by 29 percent and 10 percent, respectively. At the bottom end of the sampling, only 1 percent to 3 percent of the people questioned gave top votes to electronics, computer, space, defense, and transportation research--among the most heavily funded areas of scientific inquiry.

"The American love affair with medical research continues," notes a statement from the pollster.

A nationwide cross section of 1,255 people was polled by telephone by the Harris organization between March 18 and 24. The poll is accurate to plus or minus 3 percentage points, at 95 percent certainty.

When asked in which areas they would like to see more--or less--money spent, 91 percent of people questioned said the country should spend more on medical research. Only 5 percent thought less should be ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies